The Modern Urologist

New Technologies Lead to Better Patient Outcomes

10.22.2019 - By Myriad GeneticsPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this episode Dr. Cohen sits down with Dr. Jonathan Henderson, CEO of Regional Urology in Shreveport Louisiana to discuss how the Prolaris test changed his treatment decision of multiple patients considering treatment or active surveillance. Dr. Henderson also talks about his reasoning for the early adoption of hereditary cancer screening and shares a compelling story about how genetic testing for BRCA status allowed him to get a compassionate writ for the PARP inhibitor - Lymparza which dramatically changed his patient's quality of life. 

More episodes from The Modern Urologist